PL BioScience GmbH | Finanzwire

BRIEF

published on 06/11/2025 at 10:05, 9 months 6 days ago

PL BioScience Appoints Oliver Dick as CTO Amid Global Expansion

Global Expansion Cell Culture PL BioScience Oliver Dick HPL
PRESS RELEASE

published on 06/11/2025 at 10:00, 9 months 6 days ago

PL BioScience Strengthens Management Team with Appointment of Oliver Dick as Chief Technology Officer
PL BioScience strengthens management team with appointment of Oliver Dick as Chief Technology Officer. Oliver Dick brings 30 years of expertise in life science, diagnostic, and biopharma operations

Chief Technology Officer Biopharmaceutical Life Science PL BioScience Oliver Dick
BRIEF

published on 05/19/2025 at 15:05, 9 months 29 days ago

PL BioScience and DewCell Partner on Artificial Human Platelets

Biotech Collaboration Artificial Platelets Cell Culture Media HPL Development Animal-free Solutions
PRESS RELEASE

published on 05/19/2025 at 15:00, 9 months 29 days ago

PL BioScience and DewCell sign LOI to Jointly Develop Artificial Human Platelets for Scalable, Animal-Free Cell Culture Media
PL BioScience and DewCell sign LOI to jointly develop artificial human platelets for scalable, animal-free cell culture media. The collaboration aims to meet demand driven by regulatory trends in cell- and gene therapy development

PL BioScience Cell Culture Media DewCell Artificial Human Platelets Regulatory Trends
BRIEF

published on 05/08/2025 at 14:05, 10 months 9 days ago

PL BioScience Unveils World's First Artificial Human Platelet Lysate

Regenerative Medicine Biopharmaceuticals Cell Culture PL BioScience Artificial HPL
PRESS RELEASE

published on 05/08/2025 at 14:00, 10 months 9 days ago

PL BioScience Raises the Bar in Cell Culture Technology with First Artificial Human Platelet Lysate Worldwide
PL BioScience GmbH introduces first artificial Human Platelet Lysate (HPL) worldwide, revolutionizing cell culture technology for biopharmaceutical applications

Biopharmaceutical Human Platelet Lysate PL BioScience Artificial Cell Culture Technology
BRIEF

published on 04/30/2025 at 12:05, 10 months 17 days ago

PL BioScience Unveils Unique Gamma-irradiated Human Platelet Lysate

Regenerative Medicine Cell Therapy Human Platelet Lysate Gamma-Irradiation Xeno-Free Supplement
PRESS RELEASE

published on 04/30/2025 at 12:00, 10 months 17 days ago

PL BioScience Launches World’s Only Patented Gamma-irradiated Human Platelet Lysate
PL BioScience launches ELAREM™ Ultimate-FD PLUS, the only gamma-irradiated, GMP-grade Human Platelet Lysate in Europe. The product offers a safer, sustainable, virus-inactivated, and animal-free alternative for cell manufacturing applications

GMP-grade Human Platelet Lysate PL BioScience ELAREM Ultimate-FD PLUS Gamma-irradiated

Published on 03/17/2026 at 13:30, 5 hours 17 minutes ago

Hillcrest Energy Technologies Confirms ZVS PCS1000 Prototype on Track for June 2026
Published on 03/17/2026 at 13:30, 5 hours 17 minutes ago

Namibia Critical Metals Welcomes Toyota Tsusho as Strategic Partner in the Lofdal Heavy Rare Earths Project
Published on 03/17/2026 at 13:00, 5 hours 47 minutes ago

Avant Brands Announces Strategic Realignment of European Operations and Reclaims BLK MKT Brand Rights in Germany and Switzerland
Published on 03/17/2026 at 13:00, 5 hours 47 minutes ago

High-Resolution Airborne Survey Completed at Music Valley HREE Project
Published on 03/17/2026 at 12:30, 6 hours 17 minutes ago

Revival Gold Targets Underground Resource Growth With Drilling at Beartrack-Arnett Gold Project in Idaho

View all ACCESSWIRE

Published on 03/17/2026 at 18:07, 40 minutes ago

POS-Transaction in Own Shares
Published on 03/17/2026 at 17:58, 49 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/17/2026 at 17:45, 1 hour 2 minutes ago

FIGEAC AÉRO: THREE NEW WINS IN MEXICO
Published on 03/17/2026 at 15:30, 3 hours 17 minutes ago

Original-Research: Desert Gold Ventures Inc. (von GBC AG): Buy
Published on 03/17/2026 at 15:19, 3 hours 28 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group PLC

View all EQS

Published on 03/17/2026 at 07:00, 11 hours 47 minutes ago

Invitation to the Extraordinary General Meeting of shareholders
Published on 03/16/2026 at 18:00, 1 day ago

Disclosure of trading in own shares from 09/03/2026 to 13/03/2026
Published on 03/16/2026 at 17:58, 1 day ago

Aéroports de Paris S.A - February 2026 traffic figures
Published on 03/16/2026 at 17:56, 1 day ago

Reporting on share buyback transactions carried out between March 9 and March 13, 2026
Published on 03/16/2026 at 17:45, 1 day 1 hour ago

Weekly share buyback

View all LES ECHOS COMFI WIRE

News